Pentoxifylline 400 MG ( DrugBank: Pentoxifylline )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	2

97. Ulcerative colitis

---

Clinical trials : 2,630 /  Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05575505 (ClinicalTrials.gov)	February 2, 2023	8/10/2022	Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.	Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.	Inflammatory Bowel Diseases	Drug: Pentoxifylline 400 MG	Tanta University	NULL	Recruiting	18 Years	75 Years	All	44	Phase 2	Egypt
2	NCT05558761 (ClinicalTrials.gov)	October 10, 2022	25/9/2022	Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colitis Treated With Mesalamine	Inflammatory Bowel Diseases	Drug: Pentoxifylline 400 MG	Tanta University	NULL	Recruiting	18 Years	75 Years	All	50	Phase 2	Egypt